Med Page Today
MARCH 28, 2024
(MedPage Today) -- Human brains appeared to be getting bigger, temporal trends showed. From the 1930s to 1970s, brain volumes and cortical surface area of people who had neither dementia nor stroke became progressively larger, reported Charles.
Science Daily - Heart Disease
MARCH 28, 2024
Young to middle-aged women who reported drinking eight or more alcoholic beverages per week--more than one per day, on average--were significantly more likely to develop coronary heart disease compared with those who drank less, finds a study presented at the American College of Cardiology's Annual Scientific Session. The risk was highest among both men and women who reported heavy episodic drinking, or 'binge' drinking, and the link between alcohol and heart disease appears to be especially str
Dr. Smith's ECG Blog
MARCH 28, 2024
A 69 y.o. male with pertinent past medical history including Atrial fibrillation, atrial flutter, cardiomyopathy, Pulmonary Embolism, and hypertension presented to the Emergency Department via ambulance for respiratory distress and tachycardia. Per EMS report, patient believes he has been in atrial fibrillation for 5 days, since coming down with flu-like illness with rhinorrhea, productive cough, SOB.
Science Daily - Heart Disease
MARCH 28, 2024
Whether you like your eggs sunny-side up, hard boiled or scrambled, many hesitate to eat them amid concerns that eggs may raise cholesterol levels and be bad for heart health. However, results from a prospective, controlled trial show that over a four-month period cholesterol levels were similar among people who ate fortified eggs most days of the week compared with those who didn't eat eggs.
DAIC
MARCH 28, 2024
milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.
Science Daily - Heart Disease
MARCH 28, 2024
There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to new studies.
DAIC
MARCH 28, 2024
milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024. The study describes the validation of Cleerly's artificial intelligence-guided quantitative coronary CT angiography (AI-QCT) ISCHEMIA technology for diagnostic accuracy and prognostic risk strat
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
MARCH 28, 2024
milla1cf Thu, 03/28/2024 - 07:28 March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. Food & Drug Administration ( FDA ). The submission was supported by results from the admIRE study , a prospective, multi-center, non-randomized trial.
Science Daily - Stroke
MARCH 28, 2024
A stroke often impacts a person's ability to move their lower body from the hips down to the feet. This leads to diminished quality of life and mental health in addition to increased susceptibility to falls. But now, researchers are exploring new treatment methods to help bridge the service delivery gap, and recovery outcomes, for patients after a stroke.
Medical Xpress - Cardiology
MARCH 28, 2024
Magnesium is a mineral critical to a wide range of biological functions, and a new study takes aim at how it's transported to address cardiac dysfunction and other diseases, opening new possibilities for treatment.
HCPLive
MARCH 28, 2024
A single administration of ABBV-RGX-314 was generally well tolerated, with little to no supplemental anti-VEGF injections required in most patients at two years.
Med Page Today
MARCH 28, 2024
(MedPage Today) -- In this video, Mikhail Varshavski, DO -- who goes by "Dr. Mike" on social media -- gives a history lesson on the heart, including cultural depictions and the evolution of our understanding of anatomy. Following is a.
Medical Xpress - Cardiology
MARCH 28, 2024
There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to studies at the University of Gothenburg.
Science Daily - Heart Disease
MARCH 28, 2024
Researchers have studied hundreds of elements of the built environment, including buildings, green spaces, pavements and roads, and how these elements relate to each other and influence coronary artery disease in people living in these neighborhoods. Their findings show that these factors can predict 63% of the variation in the risk of coronary heart disease from one area to another.
Cardiovascular Diabetology
MARCH 28, 2024
Diabetes-induced trained immunity contributes to the development of atherosclerosis and its complications. This study aimed to investigate in humans whether epigenetic signals involved in immune cell activatio.
HCPLive
MARCH 28, 2024
In this episode, all things AID from the 17th annual ATTD, including updates from Insulet Corporation and Omnipod, study data from the Control IQ algorithm, the SMASH study, and a peak into the future with the Neural Network AID algorithm.
Becker's Hospital Review - Cardiology
MARCH 28, 2024
Young adults prescribed stimulant medications for attention-deficit/hyperactivity disorder are 57% more likely to develop cardiomyopathy after eight years compared to those not on stimulants, a new study found.
HCPLive
MARCH 28, 2024
The investigators seek to replicate the data in a future randomized control trial, and they hope to compare biofeedback to different therapies such as pulmonary rehabilitation.
American College of Cardiology
MARCH 28, 2024
The following are key points to remember from a state-of-the-art review on the evolving concept of secondary mitral regurgitation (MR) phenotypes and lessons from the mitral transcatheter edge-to-edge repair (M-TEER) trials.
HCPLive
MARCH 28, 2024
The recent rise in colorectal cancer incidence and mortality in younger patients has sparked a serious discussion about strategies to increase screening uptake and adherence, raising questions about the role of noninvasive tests versus the traditional “gold standard,” colonoscopy.
Cardiovascular Diabetology
MARCH 28, 2024
Coronary inflammation plays crucial role in type 2 diabetes mellitus (T2DM) induced cardiovascular complications. Both glucose-lowering drug interventions (GLDIS) and glycemic control (GC) status potentially c.
HCPLive
MARCH 28, 2024
The first quarterly issue of 2024 reviews a promising JAK inhibitor for acute severe ulcerative colitis, fenofibrates in PBC, new recommendations from the AGA, and a next generation multi-target DNA stool test for detecting colorectal cancer.
All About Cardiovascular System and Disorders
MARCH 28, 2024
Transcript of the video: Brugada Syndrome was described by Brugada brothers in 1992 as right bundle branch block pattern in anterior leads with ST segment elevation and syncope or sudden cardiac death and it was later in 1998, that the genetic basis of the disease was identified, with mutations in sodium channel. Later on, several other mutations have been attributed to cause the ECG pattern in Brugada syndrome.
HCPLive
MARCH 28, 2024
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
American College of Cardiology
MARCH 28, 2024
What is the performance of an artificial intelligence (AI)-derived risk score in predicting 1-year outcomes of patients with secondary mitral regurgitation (SMR) undergoing transcatheter edge-to-edge repair (TEER)?
HCPLive
MARCH 28, 2024
In part 2 of our 5-part discussion, experts discuss challenges they face getting patients to engage in screening and how to effectively discuss screening with patients.
American College of Cardiology
MARCH 28, 2024
For patients on the heart transplant waiting list, what association does race and gender have with the probability of donor heart offers being accepted?
HCPLive
MARCH 28, 2024
Kenneth Saag, MD, explores the clinical significance of a study demonstrating treatment with pegloticase leads to bone remodeling in patients with gout.
Circulation
MARCH 28, 2024
Circulation, Ahead of Print. Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Wearables allow patients to access their personal data and monitor their health. Despite substantial technologic advances in recent years, issues with hardware design, data analysis, and integration into the clinical workflow prevent wearables from reaching their potential in high-risk congenital heart disea
HCPLive
MARCH 28, 2024
In part 3 of our 5-part discussion, experts discuss the importance of screening among younger patient populations and strategies to encourage screening in patient populations susceptible to nonadherence.
Medical Xpress - Cardiology
MARCH 28, 2024
In a Leicester study that looked at whether artificial intelligence (AI) can be used to predict whether a pe 100 29351 0 29351 0 0 258k 0 --:--:-- --:--:-- --:--:-- 260k rson was at risk of a lethal heart rhythm, an AI tool correctly identified the condition 80% of the time.
HCPLive
MARCH 28, 2024
An expert retina specialist discusses challenges faced by DME patients showing suboptimal response to standard anti-VEGF treatment, emphasizing the need to reduce injection burden while preventing vision loss.
Medical Xpress - Cardiology
MARCH 28, 2024
Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels and is a leading cause of death globally. Lifestyle factors have been linked to the incidence of CVD and the inclusion of an active, healthy lifestyle along with other therapeutic interventions may help combat CVD.
HCPLive
MARCH 28, 2024
Ehsan Rahimy, MD, outlines strategies for managing cases of high-risk PDR and DME, exploring new therapies and synergistic combinations with anti-VEGF and steroids for longer-lasting responses.
Hypertension Journal
MARCH 28, 2024
Hypertension, Ahead of Print. The pioneering work of Dr Lewis K. Dahl established a relationship between kidney, salt, and high blood pressure (BP), which led to the major genetic-based experimental model of hypertension. BP, a heritable quantitative trait affected by numerous biological and environmental stimuli, is a major cause of morbidity and mortality worldwide and is considered to be a primary modifiable factor in renal, cardiovascular, and cerebrovascular diseases.
HCPLive
MARCH 28, 2024
Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai discuss VISIBLE trial, a randomized clinical trial specifically designed to examine treatment outcomes with guselkumab in patients with skin of color.
NEJM Journal Watch - Cardiology
MARCH 28, 2024
In a retrospective study, patients with markedly elevated aortic gradients had similarly poor prognosis regardless of whether estimated valve area was severely or moderately reduced.
Expert insights. Personalized for you.
142 
Let's personalize your content